Neil Kumar Insider Trading Activity
Neil Kumar has been net-selling over the last 12 months with 0 purchases and 105 sales across 1 company.
BBIO is the most-traded position with 105 trades. The largest single transaction was a sale of BBIO for $2.1M on Dec 15, 2025.
Performance Scorecard
Forward stock performance after each transaction by Neil Kumar. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -3.5% | 46% | 110 |
| 90 days | — | -8.5% | 49% | 95 |
| 120 days | — | -12.3% | 43% | 88 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersBBIO · BridgeBio Pharma, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Neil Kumar bought and sold BBIO.
Upgrade to ProRecent Trades
Showing the 50 most recent of 110 disclosed trades.
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 21, 2026 Filed 3d late | BBIO | Sell | 2,256 | $67.57 | $152K | −0.8% | CEO | |
May 21, 2026 Filed 3d late | BBIO | Sell | 11,250 | $70.48 | $793K | −4.4% | CEO | |
May 21, 2026 Filed 3d late | BBIO | Sell | 6,725 | $68.30 | $459K | −2.5% | CEO | |
May 21, 2026 Filed 3d late | BBIO | Sell | 800 | $70.92 | $57K | −0.3% | CEO | |
May 21, 2026 Filed 3d late | BBIO | Sell | 5,072 | $69.22 | $351K | −1.9% | CEO | |
May 8, 2026 | BBIO | Sell | 5,076 | $67.35 | $342K | −0.1% | CEO | |
May 8, 2026 | BBIO | Sell | 5,077 | $67.35 | $342K | −0.9% | CEO | |
May 8, 2026 | BBIO | Sell | 13,973 | $66.65 | $931K | −2.4% | CEO | |
May 8, 2026 | BBIO | Sell | 950 | $68.35 | $65K | −0.2% | CEO | |
May 8, 2026 | BBIO | Sell | 13,974 | $66.65 | $931K | −0.3% | CEO | |
May 7, 2026 | BBIO | Sell | 8,333 | $68.38 | $570K | −1.4% | CEO | |
May 7, 2026 | BBIO | Sell | 11,217 | $67.50 | $757K | −1.9% | CEO | |
May 7, 2026 | BBIO | Sell | 8,334 | $68.38 | $570K | −0.2% | CEO | |
May 7, 2026 | BBIO | Sell | 449 | $69.09 | $31K | −0.0% | CEO | |
May 7, 2026 | BBIO | Sell | 450 | $69.09 | $31K | −0.1% | CEO | |
Apr 10, 2026 | BBIO | Sell | 20,000 | $74.60 | $1.5M | −3.2% | CEO | |
Apr 9, 2026 | BBIO | Sell | 5,300 | $74.60 | $395K | −0.8% | CEO | |
Apr 9, 2026 | BBIO | Sell | 7,800 | $75.53 | $589K | −0.2% | CEO | |
Apr 9, 2026 | BBIO | Sell | 7,072 | $73.64 | $521K | −0.2% | CEO | |
Apr 9, 2026 | BBIO | Sell | 7,200 | $73.64 | $530K | −1.1% | CEO | |
Apr 9, 2026 | BBIO | Sell | 5,128 | $74.57 | $382K | −0.1% | CEO | |
Apr 9, 2026 | BBIO | Sell | 7,500 | $75.55 | $567K | −1.2% | CEO | |
Mar 13, 2026 | BBIO | Sell | 10,241 | $68.39 | $700K | −0.2% | CEO | |
Mar 13, 2026 | BBIO | Sell | 10,310 | $69.20 | $713K | −1.6% | CEO | |
Mar 13, 2026 | BBIO | Sell | 9,690 | $68.36 | $662K | −1.5% | CEO | |
Mar 13, 2026 | BBIO | Sell | 9,759 | $69.23 | $676K | −0.2% | CEO | |
Mar 12, 2026 | BBIO | Sell | 5,815 | $69.29 | $403K | −0.1% | CEO | |
Mar 12, 2026 | BBIO | Sell | 13,885 | $68.47 | $951K | −0.3% | CEO | |
Mar 12, 2026 | BBIO | Sell | 5,363 | $69.32 | $372K | −0.8% | CEO | |
Mar 12, 2026 | BBIO | Sell | 300 | $70.15 | $21K | −0.0% | CEO | |
Mar 12, 2026 | BBIO | Sell | 14,337 | $68.48 | $982K | −2.1% | CEO | |
Feb 19, 2026 | BBIO | Sell | 18,923 | $71.03 | $1.3M | −7.2% | CEO | |
Feb 19, 2026 | BBIO | Sell | 8,528 | $72.08 | $615K | −3.5% | CEO | |
Feb 19, 2026 | BBIO | Sell | 602 | $72.80 | $44K | −0.3% | CEO | |
Feb 11, 2026 | BBIO | Sell | 3,775 | $71.46 | $270K | −0.1% | CEO | |
Feb 11, 2026 | BBIO | Sell | 4,404 | $72.65 | $320K | −0.1% | CEO | |
Feb 11, 2026 | BBIO | Sell | 3,716 | $71.44 | $265K | −0.5% | CEO | |
Feb 11, 2026 | BBIO | Sell | 7,860 | $70.70 | $556K | −0.2% | CEO | |
Feb 11, 2026 | BBIO | Sell | 3,994 | $73.25 | $293K | −0.6% | CEO | |
Feb 11, 2026 | BBIO | Sell | 4,484 | $72.64 | $326K | −0.7% | CEO | |
Feb 11, 2026 | BBIO | Sell | 7,806 | $70.69 | $552K | −1.1% | CEO | |
Feb 11, 2026 | BBIO | Sell | 3,961 | $73.25 | $290K | −0.1% | CEO | |
Feb 10, 2026 | BBIO | Sell | 5,799 | $72.28 | $419K | −0.8% | CEO | |
Feb 10, 2026 | BBIO | Sell | 5,960 | $72.27 | $431K | −0.1% | CEO | |
Feb 10, 2026 | BBIO | Sell | 14,040 | $71.80 | $1.0M | −0.3% | CEO | |
Feb 10, 2026 | BBIO | Sell | 14,201 | $71.80 | $1.0M | −2.0% | CEO | |
Jan 9, 2026 | BBIO | Sell | 2,151 | $75.75 | $163K | −0.3% | CEO | |
Jan 9, 2026 | BBIO | Sell | 6,955 | $76.72 | $534K | −0.9% | CEO | |
Jan 9, 2026 | BBIO | Sell | 10,519 | $77.61 | $816K | −1.4% | CEO | |
Jan 9, 2026 | BBIO | Sell | 375 | $78.19 | $29K | −0.1% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 110 | $57.8M |
Other insiders at BridgeBio Pharma, Inc.
8 other tracked filers at BBIO.